Novel approach to prevent the transition from the hyperdynamic phase to the hypodynamic phase of sepsis: Role of adrenomedullin and adrenomedullin binding protein-1

Annals of Surgery

Volumn 236, Issue 5, 2002, Pages 625-633

  Yang, Shaolong ^a   Zhou, Mian ^a   Chaudry, Irshad H ^a   Wang, Ping ^a,b  

^a Kentucky   (United States)

^b North Shore Long Island Jewish Research Institute ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENOMEDULLIN; ADRENOMEDULLIN BINDING PROTEIN 1; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BINDING PROTEIN; LACTIC ACID; RADIOACTIVE MICROSPHERE; UNCLASSIFIED DRUG; VASODILATOR AGENT;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CARDIOVASCULAR RESPONSE; CONTROLLED STUDY; DISEASE COURSE; DRUG POTENTIATION; HEART OUTPUT; HEART STROKE VOLUME; HEMOCONCENTRATION; HEMODYNAMICS; LACTATE BLOOD LEVEL; LIVER INJURY; MALE; NONHUMAN; ORGAN BLOOD FLOW; OSMOTIC PUMP; OXYGEN CONSUMPTION; PRIORITY JOURNAL; RAT; SEPSIS; VASCULAR RESISTANCE;

ADRENOMEDULLIN; ALANINE TRANSAMINASE; ANIMALS; ASPARTATE AMINOTRANSFERASES; CARDIAC OUTPUT; CARRIER PROTEINS; HEMATOCRIT; HEMODYNAMIC PROCESSES; INTESTINES; LACTIC ACID; LIVER CIRCULATION; MALE; OXYGEN; PEPTIDES; RATS; RATS, SPRAGUE-DAWLEY; SEPSIS; VASODILATOR AGENTS;

EID: 0036830201     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000658-200211000-00013     Document Type: Article

References (31)

1. Bone RC. Sepsis and its complications: The clinical problem. Crit Care Med 1994; 22:S8-S11.
2. Baue AE, Durham R, Faist E. Systemic inflammatory response syndrome (SIRS), multiple organ dysfunction syndrome (MODS), multiple organ failure (MOF): Are we winning the battle? Shock 1998; 10:79-89.
3. Baue AE. Multiple organ failure, multiple organ dysfunction syndrome, and systemic inflammatory response syndrome: Why no magic bullets? Arch Surg 1997; 132:703-707.
4. Koo DJ, Chaudry IH, Wang P. Mechanism of hepatocellular dysfunction during sepsis: The role of gut-derived norepinephrine. Int J Mol Med 2000; 5:457-465.
5. Wang P, Chaudry IH. A single-hit model of polymicrobial sepsis: Cecal ligation and puncture. Sepsis 1993; 2:227-233.
6. Koo DJ, Zhou M, Chaudry IH, et al. The role of adrenomedullin in producing differential hemodynamic responses during sepsis. J Surg Res 2001; 95:207-218.
7. Wang P, Zhou M, Ba ZF, et al. Up-regulation of a novel potent vasodilator peptide adrenomedullin during polymicrobial sepsis. Shock 1998; 10:118-122.
8. Wang P, Ba ZF, Cioffi WG, et al. The pivotal role of adrenomedullin in producing hyperdynamic circulation during the early stage of sepsis. Arch Surg 1998; 133:1298-1304.
9. Wang P, Yoo P, Zhou M, et al. Reduction in vascular responsiveness to adrenomedullin during sepsis. J Surg Res 1999; 85:59-65.
10. Elsasser TH, Kahl S, Martinez A, et al. Adrenomedullin binding protein in the plasma of multiple species: Characterization by radioligand blotting. Endocrinology 1999; 140:4908-4911.
11. Pio R, Martinez A, Unsworth EJ, et al. Complement factor H is a serum binding protein for adrenomedullin. The resulting complex modulates the bioactivities of both partners. J Biol Chem 2001; 276:12292-12300.
12. Shindo T, Kurihara H, Maemura K, et al. Hypotension and resistance to lipopolysaccharide-induced shock in transgenic mice overexpressing adrenomedullin in their vasculature. Circulation 2000; 101:2309-2316.
13. Chaudry IH, Wichterman KA, Baue AE. Effect of sepsis on tissue adenine nucleotide levels. Surgery 1979; 85:205-211.
14. Wang P, Ba ZF, Chaudry IH. Increase in hepatic blood flow during early sepsis is due to increased portal blood flow. Am J Physiol 1991; 261:R1507-R1512.
15. Yang S, Cioffi WG, Bland KI, et al. Differential alterations in systemic and regional oxygen delivery and consumption during the early and late stages of sepsis. J Trauma 1999; 47:706-712.
16. Yang S, Koo DJ, Chaudry IH, et al. The important role of the gut in initiating the hyperdynamic response during early sepsis. J Surg Res 2000; 89:31-37.
17. Kitamura K, Kangawa K, Kawamoto M, et al. Adrenomedullin. A novel hypotensive peptide isolated from human pheochromocytoma. Biochem Biophys Res Commun 1993; 192:553-560.
18. Samson WK, Resch ZT, Murphy TC, et al. Adrenomedullin: Is there physiological relevance in the pathology and pharmacology? News Physiol Sci 1999; 14:255-259.
19. Eguchi S, Hirata Y, Iwasaki H, et al. Structure-activity relationship of adrenomedullin, a novel vasodilatory peptide, in cultured rat vascular smooth muscle cells. Endocrinology 1994; 135:2454-2458.
20. Eguchi S, Hirata Y, Kano H, et al. Specific receptors for adrenomedullin in cultured rat vascular smooth muscle cells. FEBS Lett 1994; 340:226-230.
21. Montuenga LM, Martinez A, Miller MA, et al. Expression of adrenomedullin and its receptor during embryogenesis suggests autocrine or paracrine modes of action. Endocrinology 1997; 138:440-451.
22. 2+ mobilization, in bovine aortic endothelial cells. J Biol Chem 1995; 270:4412-4417.
23. Ripoche J, Day AJ, Harris TJ, et al. The complete amino acid sequence of human complement factor H. Biochem J 1988; 249:593-602.
24. Friese MA, Hellwage J, Jokiranta TS, et al. Different regulation of factor H and FHL-1/reconectin by inflammatory mediators and expression of the two proteins in rheumatoid arthritis (RA). Clin Exp Immunol 2000; 121:406-415.
25. Blackmore TK, Hellwage J, Sadlon TA, et al. Identification of the second heparin-binding domain in human complement factor H. J Immunol 1998; 160:3342-3348.
26. Blackmore TK, Sadlon TA, Ward HM, et al. Identification of a heparin binding domain in the seventh short consensus repeat of complement factor H. J Immunol 1996; 157:5422-5427.
27. Pangburn MK, Atkinson MA, Meri S. Localization of the heparin-binding site on complement factor H. J Biol Chem 1991; 266:16847-16853.
28. DiScipio RG, Daffern PJ, Schraufstatter IU, et al. Human polymorphonuclear leukocytes adhere to complement factor H through an interaction that involves alphaM-beta2 (CD11b/CD18). J Immunol 1998; 160:4057-4066.
29. Wang P, Chaudry IH. Mechanism of hepatocellular dysfunction during hyperdynamic sepsis. Am J Physiol 1996; 270:R927-R938.
30. Deitch EA. Animal models of sepsis and shock: A review and lessons learned. Shock 1998; 9:1-11.
31. Dobrzynski E, Wang C, Chao J, et al. Adrenomedullin gene delivery attenuates hypertension, cardiac remodeling, and renal injury in deoxycorticosterone acetate-salt hypertensive rats. Hypertension 2000; 36:995-1001.